Publications by authors named "Xiao-Kang Zeng"

Direct percutaneous coronary intervention (PPCI) has significantly reduced cardiac mortality in patients with acute myocardial infarction (AMI), but the mortality rate remains high for those who develop cardiogenic shock (CS), reaching 40% to 50%. Veno-arterial extracorporeal membrane oxygenation (V-A ECMO) provides robust hemodynamic support and oxygen delivery for AMI patients with refractory CS, ensuring adequate organ perfusion and oxygen supply. However, there is currently no standardized optimal Mean Arterial Pressure (MAP) range during V-A ECMO support.

View Article and Find Full Text PDF

The application of Venovenous (VV) extracorporeal membrane oxygenation (ECMO) in trauma and patients with severe bleeding tendency has been controversial. However, VV ECMO without anticoagulation contributes to reducing the risk of bleeding during ECMO maintenance. VV ECMO serves critical roles in therapy of patients with severe pulmonary infection and failure in conventional therapy.

View Article and Find Full Text PDF
Article Synopsis
  • Scientists are studying how mesenchymal stem cells (MSCs) can help treat severe acute pancreatitis (SAP) by making blood vessels healthier.
  • They tested MSCs taken from human umbilical cords that were treated with a chemical called Angiotensin-II to see if they could reduce damage in rats with SAP.
  • The results showed that these treated MSCs helped heal the pancreas, improved blood vessel formation, and protected certain cells from dying, showing promise for better treatments for SAP!
View Article and Find Full Text PDF